CENCORA, INC. Equity Method Investment, Realized Gain (Loss) on Disposal
CENCORA, INC. (COR) reported Equity Method Investment, Realized Gain (Loss) on Disposal of $39.70 million for the 12-month period ending 2025-09-30, per its 8-K filed 2026-02-10.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal · last filed 2026-08-05
- CENCORA, INC. equity method investment, realized gain (loss) on disposal for the quarter ending 2025-09-30 was $0.00.
- CENCORA, INC. equity method investment, realized gain (loss) on disposal for the quarter ending 2025-06-30 was $39.70M.
- CENCORA, INC. equity method investment, realized gain (loss) on disposal for the quarter ending 2020-09-30 was $0.00.
- CENCORA, INC. equity method investment, realized gain (loss) on disposal for the quarter ending 2019-09-30 was $0.00.
- CENCORA, INC. equity method investment, realized gain (loss) on disposal for fiscal 2021 was $0.00.
- CENCORA, INC. equity method investment, realized gain (loss) on disposal for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- CENCORA, INC. equity method investment, realized gain (loss) on disposal for fiscal 2019 was $13.69M.
- CENCORA, INC. equity method investment, realized gain (loss) on disposal for fiscal 2018 was $0.00.
| Period end | Equity Method Investment, Realized Gain (Loss) on Disposal 3 month | Equity Method Investment, Realized Gain (Loss) on Disposal 6 month | Equity Method Investment, Realized Gain (Loss) on Disposal 9 month | Equity Method Investment, Realized Gain (Loss) on Disposal 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2026-02-10 | $39.70M derived: sum of 2 quarters · filed 2026-08-05 | $39.70M 8-K · filed 2026-02-10 | |
| 2025-06-30 | $39.70M 10-Q · filed 2026-08-05 | $39.70M 10-Q · filed 2026-08-05 | ||
| 2021-09-30 | $0.00 10-K · filed 2021-11-23 | |||
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-23 | $0.00 10-K · filed 2021-11-23 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-05 | |||
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-23 | $0.00 derived: sum of 2 quarters · filed 2021-11-23 | $13.69M 10-K · filed 2021-11-23 | |
| 2019-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-05 | $13.69M 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $13.69M 10-Q · filed 2020-05-07 | |||
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-19 | $0.00 derived: sum of 2 quarters · filed 2020-11-19 | $0.00 10-K · filed 2020-11-19 | |
| 2018-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-02 | |||
| 2017-09-30 | $0.00 10-K · filed 2019-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |